BioMarin Pharmaceutical

NASDAQ: BMRN
$82.49
+$2.98 (+3.7%)
Closing price March 30, 2020
Tuesday's top analyst calls included Advanced Micro Devices, Alcoa, Biomarin Pharmaceutical, Coca-Cola, Ford, General Motors, Intel, Kinder Morgan, Micron Technology, Nvidia, Tesla, Twitter and...
Jon C. Ogg
24/7 Wall St. has put together a preview of AbbVie, American Airlines, Netflix, Starbucks and some of the other most prominent earnings reports due in this truncated trading week.
Chris Lange
These five top stocks spread across different sectors offer tremendous upside to the Goldman Sachs price objectives.
Lee Jackson
Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva Pharmaceutical and Xerox.
Jon C. Ogg
Wednesday's top analyst upgrades, downgrades and initiations included Advanced Micro Devices, Apple, Biomarin, Corning, Electronic Arts, FireEye, Grubhub, Nordstrom, NXP Semiconductors, Shopify and...
Jon C. Ogg
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Jon C. Ogg
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations on Wednesday included Acacia Communications, Baidu, BioMarin Pharmaceuticals, Boeing, BP, CSX, Deere, HCA, PepsiCo, Redfin, S&P Global,...
Jon C. Ogg
With the three major stock indexes trading at or near all-time highs, many investors are scratching their heads about where to look for new investment ideas at a time when interest rates have become...
Jon C. Ogg
Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and predictability in the base businesses of two key biotech leaders.
Jon C. Ogg
Shares of these five top companies offer tremendous upside to the Goldman Sachs price objective. While there is no guarantee they get there, moving just halfway to the targets would be outsized gains...
Lee Jackson
These five top stocks across five sectors offer tremendous upside to the Goldman Sachs price objectives. Moving just halfway to the targets would be outsized gains for investors.
Lee Jackson
The biotech team at SunTrust feel that it would not be a major surprise to see these six top companies post quarterly results that beat top-line Wall Street expectations.
Lee Jackson
The top analyst upgrades, downgrades and initiations seen on Wednesday included Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix and Sirius XM.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Friday included Activision Blizzard, BioMarin Pharmaceuticals, Ciena, Delta Air Lines, GlaxoSmithKline, Procter & Gamble, Regeneron...
Lee Jackson